Osteonic

At a glance

Osteonic filed 33 disclosures in the last 12 months, including 7 5% holder and 5 insider. The most recent key filing was on Oct 29: Director's holding rose by 0 sh (other change).

Revenue for 2025 was ₩45.4B, up 32.6% on 2024. Operating margin was 19.5% against 20.1% a year earlier. Debt was 49% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩26.1B and operating profit of ₩4.8B.

The 2025 annual report lists 197 employees with an average tenure of 3.5 years and average pay of ₩41.5M, #1721 of 1,829 listed companies by average pay. Its 4 directors and auditors were paid ₩305M each on average. It paid no cash dividend for 2025. 이동원 and related parties held 19.39% at year end.

From the 2025 annual report

Staff: 197 (99 men, 98 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩8.2B. Directors and auditors: 4, paid ₩1.2B in total.

No cash dividend was paid for 2025.

Largest shareholder

이동원 holds 15.18%; with 6 related parties the group holds 19.39% of common shares at year end (from 19.20% at the start of the year).

Auditor: 삼덕회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary